Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia – Case Report

Daratumumab and Romiplostim Combined Therapy for a Long-Standing Refractory Primary Immune Thrombocytopenia – Case Report

Ibrahim Zoubi,1 Amir Warwar,1,2 Shoshan Perek,1 Meir Preis1,2 1Institute of Hematology, Lady Davis Carmel Medical Center, Haifa, Israel; 2Bruce and Ruth Rappaport Faculty of Medicine, Technion- Israel Institute of Technology, Haifa, IsraelCorrespondence: Meir Preis, Institute of Hematology, Lady Dav...

Full description

Saved in:
Bibliographic Details
Main Authors: Zoubi I, Warwar A, Perek S, Preis M
Format: Article
Language:English
Published: Dove Medical Press 2025-01-01
Series:ImmunoTargets and Therapy
Subjects:
multi-refractory immune thrombocytopenia
anti cd38 directed therapy
tpo mimetic agents
case report
Online Access:https://www.dovepress.com/daratumumab-and-romiplostim-combined-therapy-for-a-long-standing-refra-peer-reviewed-fulltext-article-ITT
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/daratumumab-and-romiplostim-combined-therapy-for-a-long-standing-refra-peer-reviewed-fulltext-article-ITT

Similar Items